J.-J. Péré

A Double-Blind Comparative Study of Clozapine and Risperidone in the Management of Severe Chronic Schizophrenia

J.-M. Azorin, Gary Remington, J M Vanelle et al. · American Journal of Psychiatry · 2001 · 179 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease who Failed to Benefit from Treatment with Donepezil

Sophie Auriacombe, J.-J. Péré, Y. Loria-Kanza et al. · Current Medical Research and Opinion · 2002 · 116 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Tolerability of Entacapone as Adjunctive Therapy to Levodopa in Patients with Parkinson’s Disease and End-of-Dose Deterioration in Daily Medical Practice: An Open, Multicenter Study

Franck Durif, I. Devaux, J.-J. Péré et al. · European Neurology · 2001 · 45 citations

Medicine, Pharmacology, Pharmacotherapy +16

[Development of a neurological score for the clinical evaluation of sylvian infarctions].

J.M. Orgogozo, Rudy Capildeo, C N Anagnostou et al. · PubMed · 1983 · 44 citations

Life Sciences, Neurology, Neuroscience +14

No additional benefit of HRT on response to rivastigmine in menopausal women with AD

A.-S. Rigaud, B. Vellas, J. Touchon et al. · Neurology · 2003 · 37 citations

Medicine, Neurology, Pharmacology +17